Rapport Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $314.9M
Liabilities Breakdown FY2024
Total Liabilities: $9.5M
Asset Breakdown
Total Assets: $314.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $56.8M | 18.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.5M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $254.6M | 80.8% |
Liabilities Breakdown
Total Liabilities: $9.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.0M | 20.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.6M | 79.4% |